Steven Cohen Viking Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 133,990 shares of VKTX stock, worth $7.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
133,990Holding current value
$7.1 Million% of portfolio
0.03%Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
426Shares Held
63.1MCall Options Held
7.39MPut Options Held
5.13M-
Black Rock Inc. New York, NY8.27MShares$439 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.79MShares$413 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.59MShares$190 Million3.55% of portfolio
-
State Street Corp Boston, MA3.33MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$123 Million0.02% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.07B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...